Back to search

University of Thessaly (UTH)

In vivo dosimetry to radiotherapy and radiology patient for error determination

Abstract

dc:description

In this thesis Thermoluminescence Dosimeters (TLD) used in diagnostic, interventional radiology and radiotherapy were studied in terms of dose measurement, optimisation and radiation risk reduction for patients and staff. The presented work has two main parts: in vivo dosimetry in high energy photon beams used in radiotherapy treatments and in vivo dosimetry in low energy photon beams used in interventional radiology. The first part, intends to evaluate the feasibility of different Buildup caps materials (Copper, Aluminum, Stainless steel and Plexiglas) on the onset of supralinearity and also evaluates the accuracy obtained, measuring the entrance during head and neck, abdomen and pelvic radiotherapy. Pripheral doses (skin and thyroid) were measured during breast treatment. TLD-100 was used with different copper build up caps for 6 MV and 15 MV photon beams from two linear accelerators. The perturbation value can reach up to 20% of the dmax, which acts as a limitation for entrance dose measurements. An average thyroid skin dose of 3.7% of the prescribed dose was measured per treatment session while the mean skin dose breast treatment session is estimated to be 42% of dmax, for both internal and external fields. These results are comparable in those of the in vivo of reported in literature. The risk of fatality due to thyroid cancer per treatment course is 3x10-3. The largest spread in ratios of measured and calculated entrance doses can be found for breast cancer patients. The second part concerning medical radiology. Radiation doses were measured for frequent procedures and considered as gold standard techniques for some sensitive groups. These procedures include Micturating cystourethrography (MCU), Hysterosalpingography (HSG) and Endoscopic retrograde cholangiopancreatography (ERCP). TLD-100 and TLD-200 were used to measure patients and staff doses, respectively for their valuable characteristics. TLDs were packed on a thin envelope made of transparent plastic foil. The examiners were performing the investigations with a protocol that is designed to minimize patient and examiner dose. A total of 242 patients were investigated. The mean ESD were 1.13, 3.60 and 68.75 mGy for MCU, HSG and ERCP, respectively. Generally, the risk of cancer is ranges between 10-6 and 10 -7. Considerable variations were observed among patient populations in terms of radiation dose, and fluoroscopic time. These variations are due to the different indications, patient characteristics and pathological findings. The data analysed in this work showed our doses to be lower by approximately 50% to 300% compared to the lower mean values presented in the literature. As a general conclusion, the work of this thesis produced the following results: Calibration protocols for TLDs in high and low energies photon beams Protocols for in vivo dose verification to patients treated with radiotherapy Protocols for the determination of Diagnostic Dose Reference Levels (DRLs) that are applied in clinical practice in the interventional radiology procedures studied. The TLD dose verification protocol is now part of the QA procedure at the Radiotherapy Department of the University Hospital of Larissa.

Degree

thesis:*
Grantor dc:publisher
University of Thessaly (UTH)
Year dc:date
2008

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Sulieman, Abdelmoneim

Subjects

dc:subject × 16

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/17209

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Sulieman, Abdelmoneim. In vivo dosimetry to radiotherapy and radiology patient for error determination. University of Thessaly (UTH), 2008. http://hdl.handle.net/10442/hedi/17209